Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders
DOI:
https://doi.org/10.32947/ajps.v25i5.1307Keywords:
HDAC inhibitors, Benzyl oxybenzoate derivatives, Molecular docking, Cancer, CNS disordersAbstract
Histone deacetylase (HDAC) inhibitors have garnered attention as possible therapies for disorders affecting the central nervous system (CNS) and cancer. Because HDACs, particularly HDAC1 and HDAC2, are overexpressed in many cancers and govern neurological diseases, they are dual targets for therapeutic interventions.
Therefore, this study aims to synthesize benzyl oxybenzoate and use pharmacokinetic analyses and molecular docking to evaluate their potential as HDAC inhibitors.
After synthesizing benzoyl oxybenzoate derivatives, their potential as HDAC inhibitors was evaluated by comparing their binding affinity and mechanism to that of SAHA, a well-known HDAC inhibitor, utilizing molecular docking against HDAC2. To forecast pharmacokinetics, the ADME profiles of these substances—such as oral bioavailability and blood-brain barrier (BBB) permeability—were also assessed.
A number of synthetic compounds showed promising binding affinities against HDAC2, indicating their potential as HDAC inhibitors. According to the results, the designed compounds that were found may be investigated further as dual-action medications for CNS diseases and cancer.
References
1- Frumm SM, Fan ZP, Ross KN, et al. Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation. Chemistry & Biology. 2013 May 23;20(5):713-25. DOI: 10.1016/j.chembiol.2013.03.020
2- Kattar SD, Surdi LM, Zabierek A, et al. Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization. Bioorganic & Medicinal Chemistry Letters. 2009 Feb 15;19(4):1168-72. DOI: 10.1016/j.bmcl.2008.12.083
3- Methot JL, Hoffman DM, Witter DJ, et al. Delayed and prolonged histone hyperacetylation with a selective HDAC1/HDAC2 inhibitor. ACS Medicinal Chemistry Letters. 2014 Apr 10;5(4):340-5. DOI: 10.1021/ml500019u
4- Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Reviews Drug Discovery. 2008 Oct;7(10):854-68. DOI: 10.1038/nrd2681
5- Tang Y, Lin YH, Ni HY, et al. Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery from Stroke. Journal of the American Heart Association. 2017 Oct 5;6(10): e007236. DOI: 10.1161/JAHA.117.007236
6- Wagner FF, Zhang YL, Fass DM, et al. Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers. Chemical Science. 2015;6(1):804-15. DOI: 10.1039/C4SC02721A
7- Sada N, Fujita Y, Mizuta N, et al. Inhibition of HDAC increases BDNF expression and promotes neuronal rewiring and functional recovery after brain injury. Cell Death & Disease. 2020 Aug 18;11(8):655. DOI: 10.1038/s41419-020-02875-1
8- Schroeder FA, Lewis MC, Fass DM, et al. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests. PloS One. 2013 Aug 14;8(8):e71323. DOI: 10.1371/journal.pone.0071323
9- Mohseni J, Zabidi-Hussin ZA, Sasongko TH. Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy. Genetics and Molecular Biology. 2013; 36:299-307. DOI: 10.1590/S1415-47572013000300002
10- Andreassi C, Angelozzi C, Tiziano FD, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. European Journal of Human Genetics. 2004 Jan;12(1):59-65. DOI: 10.1038/sj.ejhg.5201080
11- Kim C, Choi H, Jung ES, et al. HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons. PLoS One. 2012;7(8):e42983. DOI: 10.1371/journal.pone.0042983
12- Kontopoulos E, Parvin JD, Feany MB. α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Human Molecular Genetics. 2006 Oct 15;15(20):3012-23. DOI: 10.1093/hmg/ddl243
13- Dompierre JP, Godin JD, Charrin BC, et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. Journal of Neuroscience. 2007 Mar 28;27(13):3571-83. DOI: 10.1523/JNEUROSCI.0037-07.2007
14- Mahdi MF, Raauf AM. Molecular modelling, Synthesis and Antiproliferative Evaluation of New Phenyldiazenyl)-Pyrazol Schiff Base Derivatives. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2024 Jan 14;24(1):25-37.
15- Jabbar ZA, Mahdi MF, Abd Razik BM. Synthesis, Characterization, ADME Study and Anti-proliferative evaluation against MCF-7 breast cancer cell line of new analog of a 4-aminophenyl quinazolinone derivative. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2023 Oct 9;23(4):411-28.
16- Raauf AMR, Omar TN, Mahdi MF, Fadhil HR. Synthesis, molecular docking and anti-inflammatory evaluation of new trisubstituted pyrazoline derivatives bearing benzenesulfonamide moiety. Nat Prod Res. 2024 Jan-Feb;38(2):253-260. doi: 10.1080/14786419.2022.2117174.
17- Razik, B. M. A., Ezzat, M. O., & Al-Shohani, A. D. H. MOLECULAR DOCKING AND DESIGN STUDY FOR ANTICANCER ACTIVITY OF FLAVONOID DERIVATIVES AGAINST BREAST CANCER. INDIAN DRUGS, 57(04), 7–14(2020). https://doi.org/10.53879/id.57.04.12202.
18- M. Mohammed and A. Amjed Adnan, “In-silico design, molecular docking, molecular dynamic simulations, Molecular mechanics with generalised Born and surface area solvation study, and pharmacokinetic prediction of novel diclofenac as anti-inflammatory compounds”, Turkish Comp Theo Chem (TC&TC), vol. 8, no. 3, pp. 108–121, 2024, doi: 10.33435/tcandtc.1355772.
19- Chennai HY, Belaidi S, Bourougaa L, Ouassaf M, Sinha L, Samadi A, et al. Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations. Molecules. 2024;29(6):1232. DOI: https://doi.org/10.3390/molecules29061232.
20- Agrawal K, Patel T, Thakur S, Patel K, Mittal S. Spectral Investigations, DFT Studies, ADME Analysis, Molecular Docking of New Piperidine Derivatives with Potential Antimicrobial Activity. J. Sci. Technol. 2023;16(35):2835-2844. DOI: https://doi.org/10.17485/IJST/v16i35.389.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dhiaa Ali Abdulkader, Monther Faisal Mahdi
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
